NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-79

  1. 405 Posts.
    Thanks Hottod, great post and much appreciated. It sure puts the challenge in some perspective with what has gone before.

    My fingers crossed that there is success this time. You can tell from the carer statements from the trials described in your post, and from our own NEU trials, that it means so much for so many.

    This time.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.